Harnessing the beneficial heterologous effects of vaccination

Helen S. Goodridge*, S. Sohail Ahmed, Nigel Curtis, Tobias R. Kollmann, Ofer Levy, Mihai G. Netea, Andrew J. Pollard, Reinout Van Crevel, Christopher B. Wilson

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

204 Scopus citations

Abstract

Clinical evidence strongly suggests that certain live vaccines, in particular bacille Calmette-Guérin (BCG) and measles vaccines, can reduce all-cause mortality, most probably through protection against non-targeted pathogens in addition to the targeted pathogen. The underlying mechanisms are currently unknown. We discuss how heterologous lymphocyte activation and innate immune memory could promote protection beyond the intended target pathogen and consider how vaccinologists could leverage heterologous immunity to improve outcomes in vulnerable populations, in particular the very young and the elderly.

Original languageEnglish
Pages (from-to)392-400
Number of pages9
JournalNature Reviews Immunology
Volume16
Issue number6
DOIs
StatePublished - 1 Jun 2016
Externally publishedYes

Funding

FundersFunder number
National Institute of Allergy and Infectious DiseasesR01AI100135
European Commission310372

    Fingerprint

    Dive into the research topics of 'Harnessing the beneficial heterologous effects of vaccination'. Together they form a unique fingerprint.

    Cite this